# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian epithelial cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 51-60 of 535 results.
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Feb 25, 2020
First Received: Feb 03, 2016
Disease(s): Ovarian Cancer
Intervention(s): Hyperthermic intraperitoneal chemotherapy (HIPEC), Carboplatin
Locations: Women's Cancer and Surgical Oncology Center, Loma Linda, California, United States
Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer
Status: Recruiting
Last Changed: Feb 12, 2020
First Received: Sep 13, 2019
Disease(s): Ovarian Cancer
Intervention(s): IMP4297
Locations: Xiaohua.Wu, Shanghai, China
Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: May 08, 2019
First Received: May 08, 2019
Disease(s): Ovarian Cancer
Intervention(s): albumin-bound paclitaxel, Apatinib
Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
Status: Recruiting
Last Changed: Dec 05, 2019
First Received: Nov 14, 2019
Disease(s): Ovarian Cancer
Intervention(s): W_ova1 Vaccine
Locations: UMCG, Groningen, Netherlands
A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Mar 29, 2019
First Received: Mar 29, 2019
Disease(s): Ovarian Cancer
Intervention(s): niraparib, Brivanib
Locations: Jing Wang, Changsha, Hunan, China
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Status: Recruiting
Last Changed: Nov 04, 2019
First Received: Oct 04, 2007
Disease(s): Ovarian Cancer
Intervention(s): Questionnaire
Locations: Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine, Miami, Florida, United States
John Stoddard Cancer Center, Des Moines, Iowa, United States
Carol G. Simon Cancer Center / Atlantic Health, Morristown, New Jersey, United States
University of Rochester Medical Center, Rochester, New York, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
... and 7 other locations.
A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Feb 12, 2020
First Received: Nov 20, 2019
Disease(s): Ovarian Cancer
Intervention(s): IMP4927, Placebos
Locations: Sun Yat-sen University Cancer Center, Guanzhou, Guangdong, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
PTC-596 in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy
Status: Recruiting
Last Changed: Nov 25, 2019
First Received: Jul 02, 2017
Disease(s): Ovarian Cancer
Intervention(s): PTC596
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
Status: Recruiting
Last Changed: Nov 04, 2019
First Received: Jun 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Manganese Chloride, nab-paclitaxel, Platinum chemotherapy, Sintilimab
Locations: Biotherapeutic Department of Chinese PLA General Hospital, Beijing, Beijing, China
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
Status: Not yet recruiting
Last Changed: Jun 06, 2018
First Received: Jun 06, 2018
Disease(s): Ovarian Cancer
Intervention(s): Apatinib